However, semaglutide has more clinical trial data and has shown benefits in treating various conditions like heart disease, kidney disease, and liver disease, sometimes independently of its effects on weight or glucose
This formula combines clinical expertise with deep understanding of digestive challenges faced by GLP-1 users and those with sensitive stomachs
How Continuous Tirzepatide Therapy Prevents Weight Cycling Instead of experiencing the weight regain seen in clinical trials, patients who maintain tirzepatide therapy show stable weight loss over 2+ years of follow-up data
Trulicity may increase the risk of thyroid cancer
While injectable semaglutide's delayed gastric emptying has not shown clinically meaningful effects on most oral medications, providers should monitor patients taking medications with narrow therapeutic windows
Lowering CRP may mean fewer or less severe flareups